Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Lance Armstrong May Cooperate With Doping Probe, USADA Says

Feb. 7 (Bloomberg) -- Lance Armstrong may cooperate with a probe into performance-enhancing drug use in cycling by the U.S. Anti-Doping Agency, which stripped him of his seven Tour de France titles and barred him from Olympic sports for life.

USADA granted a request from Armstrong for a two-week extension of its deadline for him to agree to testify under oath as part of the investigation, the agency’s Chief Executive Officer Travis Tygart said yesterday in a statement.

“We have been in communication with Mr. Armstrong and his representatives and we understand that he does want to be part of the solution and assist in the effort to clean up the sport of cycling,” Tygart said.

USADA sanctioned Armstrong, 41, in August after he opted not to contest doping charges in arbitration. The cyclist acknowledged in a television interview with Oprah Winfrey last month that he used a “cocktail” of testosterone, erythropoietin and blood doping throughout his career.

Mark Fabiani, a lawyer for Armstrong, declined to comment in an e-mail.

To contact the reporter on this story: Nancy Kercheval in Washington at

To contact the editor responsible for this story: Michael Sillup at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.